Key milestones in the development of lutetium Lu 177 vipivotide tetraxetan for the treatment of PSMA-positive mCRPC. EMA European Medicines Agency, MAA Marketing Authorization Application
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.